Literature DB >> 8764473

Development of a simple chemically defined medium for Porphyromonas gingivalis: requirement for alpha-ketoglutarate.

P Milner1, J E Batten, M A Curtis.   

Abstract

The aim of this study was the development of a simple, defined medium for the growth of laboratory and clinical isolates of Porphyromonas gingivalis. A medium was designed in which the carbon and nitrogen requirements were provided by a single protein source--bovine serum albumin. High cell yields were achieved in this medium but growth was accompanied by a heavy blackening of the cells due to the deposition of metal sulfide(s), most probably iron(II) sulfide, at the cell surface. Good growth in the absence of blackening was achieved when the iron salt in the medium was substituted with alpha-ketoglutarate. The resultant alpha-ketoglutarate/BSA medium was able to support the growth of all laboratory and clinical P. gingivalis strains examined and should prove useful in the investigation of the physiology and nutritional regulation of virulence of this organism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8764473     DOI: 10.1016/0378-1097(96)00159-0

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  24 in total

1.  Role of gingipains in growth of Porphyromonas gingivalis in the presence of human serum albumin.

Authors:  D Grenier; S Imbeault; P Plamondon; G Grenier; K Nakayama; D Mayrand
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Trimeric structure of major outer membrane proteins homologous to OmpA in Porphyromonas gingivalis.

Authors:  Keiji Nagano; Erik K Read; Yukitaka Murakami; Takashi Masuda; Toshihide Noguchi; Fuminobu Yoshimura
Journal:  J Bacteriol       Date:  2005-02       Impact factor: 3.490

3.  Identification and characterization of the capsular polysaccharide (K-antigen) locus of Porphyromonas gingivalis.

Authors:  Joseph Aduse-Opoku; Jennifer M Slaney; Ahmed Hashim; Alexandra Gallagher; Robert P Gallagher; Minnie Rangarajan; Khalil Boutaga; Marja L Laine; Arie J Van Winkelhoff; Michael A Curtis
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

4.  Lactoferrin inhibits Porphyromonas gingivalis proteinases and has sustained biofilm inhibitory activity.

Authors:  Stuart G Dashper; Yu Pan; Paul D Veith; Yu-Yen Chen; Elena C Y Toh; Sze Wei Liu; Keith J Cross; Eric C Reynolds
Journal:  Antimicrob Agents Chemother       Date:  2012-01-03       Impact factor: 5.191

5.  Sodium ion-driven serine/threonine transport in Porphyromonas gingivalis.

Authors:  S G Dashper; L Brownfield; N Slakeski; P S Zilm; A H Rogers; E C Reynolds
Journal:  J Bacteriol       Date:  2001-07       Impact factor: 3.490

6.  Comprehensive transcriptome analysis of the periodontopathogenic bacterium Porphyromonas gingivalis W83.

Authors:  Hedda Høvik; Wen-Han Yu; Ingar Olsen; Tsute Chen
Journal:  J Bacteriol       Date:  2011-10-28       Impact factor: 3.490

7.  Arginine deiminase inhibits Porphyromonas gingivalis surface attachment.

Authors:  Carla Cugini; Danielle N Stephens; Daniel Nguyen; Alpdogan Kantarci; Mary E Davey
Journal:  Microbiology       Date:  2012-12-14       Impact factor: 2.777

8.  The rag locus of Porphyromonas gingivalis contributes to virulence in a murine model of soft tissue destruction.

Authors:  Xiaoju Shi; Shirley A Hanley; Marie-Claire Faray-Kele; Stuart C Fawell; Joseph Aduse-Opoku; Robert A Whiley; Michael A Curtis; Lucinda M C Hall
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

9.  Cleavage of human transferrin by Porphyromonas gingivalis gingipains promotes growth and formation of hydroxyl radicals.

Authors:  Véronique Goulet; Bradley Britigan; Koji Nakayama; Daniel Grenier
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

10.  Effect of inactivation of the Arg- and/or Lys-gingipain gene on selected virulence and physiological properties of Porphyromonas gingivalis.

Authors:  Daniel Grenier; Sophie Roy; Fatiha Chandad; Pascale Plamondon; Masami Yoshioka; Koji Nakayama; Denis Mayrand
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.